ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate
Earnings Call: ClearPoint Neuro Sees Record Revenue of $7.9 Million
B. Riley Adjusts Price Target on ClearPoint Neuro to $10.50 From $10, Maintains Buy Rating
Express News | Clearpoint Neuro Inc : Stifel Raises Target Price to $10 From $9
ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript
Express News | ClearPoint Sees FY24 Revenue $30M-$33M Vs $30.52M Estimate
ClearPoint Neuro | 10-Q: Q2 2024 Earnings Report
Express News | ClearPoint Neuro Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
ClearPoint Neuro GAAP EPS of -$0.16 Beats by $0.02, Revenue of $7.9M Beats by $0.57M
Express News | Clearpoint Neuro Reports Second Quarter 2024 Results
Express News | Clearpoint Neuro Outlook FY Revenue USD 30-33 Million
Express News | Clearpoint Neuro Q2 Gross Margin 63%
Express News | Clearpoint Neuro Q2 Revenue USD 7.9 Million
ClearPoint Neuro 2Q Loss/Shr 16c >CLPT
ClearPoint Neuro 2Q Rev $7.86M >CLPT
ClearPoint Neuro Q2 2024 Earnings Preview
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Remains a Buy on ClearPoint Neuro (CLPT)
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $10
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024